全球前20强生物制药企业中已有6家选择Veeva China CRM Suite

美通社
04 Mar

(医药健闻2025年3月4日讯)Veeva Systems公司宣布,在全球排名前20位的生物制药企业中,已有6家选择采用Veeva China CRM Suite,以加强其与中国市场医疗保健专业人员(HCP)的互动。China CRM Suite套件产品是Veeva专为中国市场量身打造,由中国团队依托Veeva全球合规标准与质量开发流程研发,精准契合中国市场的特有需求与技术标准,服务器部署在中国境内。

Veeva China CRM Suite是Veeva商务云的核心产品之一,囊括了一系列加强客户互动的中国专属应用,包括:China CRM、China Events Management、Approved WeChat、China Engage以及China Campaign Manager。作为一项全球性解决方案,Veeva China CRM Suite可与Veeva PromoMats、Veeva Network和Veeva OpenData实现无缝协作。

海量资讯、精准解读,尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10